| Dr Byron Renard Dean, DO | |
|
1500 Lakeland Hills Blvd Ste 4, Lakeland, FL 33805 | |
| (863) 937-7157 | |
| (863) 333-0260 |
| Full Name | Dr Byron Renard Dean |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 1500 Lakeland Hills Blvd Ste 4, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104851559 | NPI | - | NPPES |
| 16757 | Other | BLUE CROSS | |
| 00396100R | Other | FL | MEDICAID GROUP # |
| EY656A | Other | FL | MEDICARE GROUP PTAN |
| 245345600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0S9203 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Lakeland, FL | Home health agency |
| Family Home Health Services | Tampa, FL | Home health agency |
| Doctors Choice Home Care Inc | Bradenton, FL | Home health agency |
| Vitas Healthcare Corporation Of Florida | Melbourne, FL | Hospice |
| Good Shepherd Hospice | Lakeland, FL | Hospice |
| Lakeland Regional Medical Center | Lakeland, FL | Hospital |
| Highlands Lake Center | Lakeland, FL | Nursing home |
| Scott Lake Health And Rehabilitation Center | Lakeland, FL | Nursing home |
| Brandywyne Health Care Center | Winter haven, FL | Nursing home |
| Swan Center At Oakbridge (the) | Lakeland, FL | Nursing home |
| Florida Presbyterian Homes Inc | Lakeland, FL | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Medical Inc | 7810174711 | 5 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
| Entity Name | Dean Medical Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619274388 PECOS PAC ID: 7810174711 Enrollment ID: O20110601000625 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
| Entity Name | Sunshine Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457733743 PECOS PAC ID: 8921317942 Enrollment ID: O20151014000841 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
| Entity Name | Total Life Health Center Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184209991 PECOS PAC ID: 8921453127 Enrollment ID: O20231008000180 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
| Entity Name | Bluebyrd Wound And Lymphatic Care And Consultation Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740064724 PECOS PAC ID: 2062867831 Enrollment ID: O20231013002242 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Byron Renard Dean, DO 3616 Harden Blvd, #311, Lakeland, FL 33803-5938 Ph: (863) 937-7157 | Dr Byron Renard Dean, DO 1500 Lakeland Hills Blvd Ste 4, Lakeland, FL 33805 Ph: (863) 937-7157 |
News Archive
Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.
Children with asthma are more likely to be prescribed antibiotics even though there is no evidence that they need them any more than children without asthma, according to research to be presented at the European Respiratory Society International Congress 2017.
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.
The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
› Verified 3 days ago
Danton Manabat Sun, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Dr. Luis Clyde Favilli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3650 Innovation Dr, Lakeland, FL 33812 Phone: 860-709-1968 Fax: 863-701-2151 | |
Greto Ramos, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4710 S Florida Ave, Lakeland, FL 33813 Phone: 863-284-6800 | |
Saundra Holseth, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3240 S Florida Ave, Lakeland, FL 33803 Phone: 863-646-4000 Fax: 863-646-5189 | |
Alex I Garriga, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6721 Crescent Lake Dr, Lakeland, FL 33813 Phone: 863-644-4547 Fax: 863-701-9453 | |
Dr. Avantica Gondi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1818 Harden Blvd Ste 120, Lakeland, FL 33803 Phone: 863-210-5640 Fax: 863-210-5716 | |
Dr. Melissa Ann Ballengee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 |